Skip to: Content
Skip to: Site Navigation
Skip to: Search

October 10, 2008 3:49:56 PM CDT

Learn about Newser Points »

« Back to the grid | Next story »

Battle Brews in Pharma's Market

Posted Nov 3, 07 6:43 PM CDT in Science & Health,  Business 

(Newser) – Pfizer is trying to stave off its own heart attack now that its flagship cholesterol-lowering drug Lipitor faces stiff competition from a cheaper generic. Lipitor is still patent-protected, but a very similar drug called Zocor isn't, and since a generic version called simvastatin hit the market, many doctors and insurers are steering patients away from Lipitor to the cheaper alternative, the New York Times says.

Pfizer isn’t taking it quietly. The company, whose stock price has tumbled to record lows, launched an advertising and lobbying campaign and has been touting a controversial British study that found a 30% increase in cardiac risks for patients who switched from Lipitor to the generic drug. Still, analysts are skeptical that Pfizer will be able to snuff out simvastatin, which costs $2/day less than Lipitor.

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
New Study On Statins (ZOCOR) MAy Reduce Risk Of Cancer   (Getty Images)
The world headquarters of Pfizer Inc. is shown in this April 12, 2005, file photo in New York. Pfizer Inc., the world's largest pharmaceutical company, said Thursday, Oct. 18, 2007 its third-quarter...   (Associated Press)
Forty-milligram tablets of the drug Lipitor are photographed in Glen Rock, N.J. in a file photo from Nov. 15, 2005. Drug makers Merck & Co. and Schering-Plough Corp. said Monday, March 26, 2007 they will...   (Associated Press)
Dr. Nicolas Abourizk, of West Hartford, and Joleen Richard, of Bolton, Connecticut, are shown during an interview at the diabetes care center at St. Francis Hospital in Hartford, Connecticut, in June   (KRT Photos)
This image received 05 June 2007 shows the logo for Pfizer. Nigeria...   (Getty Images (by Event))
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (
1
 of 3)

Tags

heart attack  • pharmaceutical companies  • cholesterol  • Pfizer  • health care industry  • insurance companies  • medical treatment  • statins  • Lipitor  • generic drugs  • Zocor  • LDL


Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Business Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »